Sun Pharma’s arm gets US FDA approval for Risperidone oral tablets: Report

12 Mar 2014 Evaluate

Sun Pharmaceutical Industries’ subsidiary Caraco has reportedly received US Food and Drug Administration (US FDA) approval for Risperidone oral tablets. The oral tablet is used for the treatment of schizophrenia (a mental disorder).

Recently, the healthcare major had voluntarily recalled 2,528 bottles of its generic version of diabetes drug Glumetza from US-based Santarus Inc after it received a customer complaint.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1623.60 11.05 (0.69%)
22-Jan-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1623.60
Dr. Reddys Lab 1223.40
Cipla 1377.65
Zydus Lifesciences 884.75
Lupin 2176.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×